BSDBS A.I CyberSecurity Scoring
06/12/2025
Access Monitoring Plan
Access Monitoring Plan
No incidents recorded for Boston Scientific Deep Brain Stimulation in 2026.
No incidents recorded for Boston Scientific Deep Brain Stimulation in 2026.
No incidents recorded for Boston Scientific Deep Brain Stimulation in 2026.
As a leading medical technology company, B. Braun protects and improves the health of people around the world. For more than 185 years, the family-owned company has been accelerating progress in health care with pioneering spirit and groundbreaking contributions. This innovative strength continues to be the foundation of B. Braun's success today—always with the goal of improving clinical outcomes, cost of care and patient benefits. More than 64,000 employees live Sharing Expertise worldwide, they make B. Braun a true partner that develops integrated solutions and sets new standards. By linking products, services and consulting, the company improves treatment processes and supports medical staff. In doing so, B. Braun always acts with future generations in mind, which is why responsibility for sustainable growth is embedded into all business processes. In 2024, the B. Braun Group generated sales of € 9.1 billion. Imprint: https://www.bbraun.com/en/imprint.html Privacy Policy: https://www.bbraun.com/en/privacy-policy.html
Alcon helps people see brilliantly. As the global leader in eye care with a heritage spanning over 75 years, we offer the broadest portfolio of products to enhance sight and improve people’s lives. Our Surgical and Vision Care products touch the lives of more than 260 million people in over 140 countries each year living with conditions like cataracts, glaucoma, retinal diseases and refractive errors. Our more than 25,000 associates are enhancing the quality of life through innovative products, partnerships with Eye Care Professionals and programs that advance access to quality eye care. Learn more at www.alcon.com.
Boston Scientific transforms lives through innovative medical technologies that improve the health of patients around the world. As a global medical technology leader for more than 40 years, we advance science for life by providing a broad range of high-performance solutions that address unmet patient needs and reduce the cost of health care. Our portfolio of devices and therapies helps physicians diagnose and treat complex cardiovascular, respiratory, digestive, oncological, neurological and urological diseases and conditions. For more information, visit www.bostonscientific.com and connect with us on X, Instagram, and Facebook. At Boston Scientific, you will find purpose, a place to grow and opportunities to cultivate your passions. To search and apply for open positions, visit https://bostonscientific.eightfold.ai/careers. You may also review our social media guidelines at http://www.bostonscientific.com/social.
STERIS is a leading provider of infection prevention and other procedural products and services, focused primarily on healthcare, pharmaceutical and medical device Customers. MISSION WE HELP OUR CUSTOMERS CREATE A HEALTHIER AND SAFER WORLD by providing innovative healthcare and life science products and services around the globe. VISION We strive to be a GREAT COMPANY. We provide world-class products and services for our Customers, safe and rewarding work for our people, and superior returns for our Shareholders. • $5 Billion in revenue in FY24 • More than 17,000 Associates worldwide • Over 4,000 Customer-facing professionals • Listed on the New York Stock Exchange under the symbol “STE” To learn more, visit www.steris.com. Want to join the team? View and apply for open roles at careers.steris.com.
Medline is the largest provider of medical-surgical products and supply chain solutions serving all points of care. Through its unique offering of world-class products, supply chain resilience and clinical practice expertise, Medline delivers improved clinical, financial and operational outcomes. Headquartered in Northfield, Illinois, the company employs 43,000 people worldwide and operates in over 100 countries and territories. To learn more about how Medline makes healthcare run better, visit www.medline.com.
We are dedicated to transforming lives by improving the journey to a healthy, beautiful smile. Discover your straight path to a bright future at Align Technology. As a part of our smart, diverse and fast-moving global team, you'll make an impact on the market leader that's moving an industry forward. Want to find out what's next for us—and for you? Follow us on LinkedIn for business updates and check out our current opportunities at www.aligntech.com/careers. 25 years ago, we pioneered the market for clear aligners. Since then, we have continuously innovated with new products and technologies that revolutionize treatments for doctors and their patients. Today, doctors and labs in over 100 markets use the Invisalign system, iTero intraoral scanners and exocad software to improve smiles for patients – from simple tooth alignment to complex corrections, kids to adults, orthodontics to multi-disciplinary restorative treatment. Learn more about Align Technology and our products: www.aligntech.com www.invisalign.com www.itero.com www.exocad.com
Danaher is a leading global life sciences and diagnostics innovator, committed to accelerating the power of science and technology to improve human health. We partner with customers across the globe to help them solve their most complex challenges, architecting solutions that bring the power of science to life. Our global teams are pioneering what’s next across Life Sciences, Diagnostics, Biotechnology and beyond. For more information, visit www.danaher.com.
Edwards Lifesciences (NYSE: EW), is the leading global structural heart innovation company, driven by a passion to improve patient lives. Through breakthrough technologies, world-class evidence and partnerships with clinicians and healthcare stakeholders, our employees are inspired by our patient-focused culture to deliver life-changing innovations to those who need them most. We thrive on discovery and expanding the boundaries of medical technology, serving patients in 100+ countries, with the help of our employees in areas including Clinical Affairs, Quality Engineering, Research & Development, Regulatory Affairs, Sales & Marketing, corporate functions and more. Contact Us We want to hear from you and engage in meaningful discussions. However, please note that we are not equipped to provide customer, candidate, or technical support through this platform. If you require assistance from those teams, please find their contact information here: https://www.edwards.com/aboutus/contactus If you’re a patient in need of medical advice, please contact your healthcare provider directly. We reserve the right to remove any comments that are off-topic, repetitive, or include hate speech, profanity, or offensive language. Additionally, we will not engage in discussions about competitor products, off-label use of Edwards products, or unsubstantiated/misleading claims that could cause harm. All Terms and Conditions of LinkedIn apply. For the Edwards Lifesciences privacy policy, visit https://www.edwards.com/legal/privacypolicy.
BD is one of the largest global medical technology companies in the world and is advancing the world of health™ by improving medical discovery, diagnostics and the delivery of care. The company supports the heroes on the frontlines of health care by developing innovative technology, services and solutions that help advance both clinical therapy for patients and clinical process for health care providers. BD and its more than 70,000 employees have a passion and commitment to help enhance the safety and efficiency of clinicians' care delivery process, enable laboratory scientists to accurately detect disease and advance researchers' capabilities to develop the next generation of diagnostics and therapeutics. BD has a presence in virtually every country and partners with organizations around the world to address some of the most challenging global health issues. By working in close collaboration with customers, BD can help enhance outcomes, lower costs, increase efficiencies, improve safety and expand access to health care. For more information on BD, please visit bd.com. See community guidelines here: https://tinyurl.com/yunjmzkx.
Latest updates, reports, and threat intel affecting the global network.
Boston Scientific's AI strategy set to dominate medical technology—integrating smart devices, talent, and data into unbeatable clinical...
Medtronic, Johnson & Johnson, Siemens Healthineers, GE HealthCare, Abbott, Stryker, BD, Philips, Boston Scientific, and Zimmer Biomet...
Boston Scientific has achieved a significant milestone with the European CE [Conformité Européenne] marking of its Vercise Neural Navigator 5 software.
The impact Elon Musk is singlehandedly having on the field of neurotechnology and brain computer interfaces through Neuralink is both undeniable and important.
Boston Scientific has concluded the acquisition of Relievant Medsystems for an upfront cash payment of $850m.
FDA has cleared Deep Brain Stimulation (DBS) and Transcranial Magnetic Stimulation (TMS) devices with updated functionality and expanded...
The US FDA has granted approval for Boston Scientific's Vercise Neural Navigator 5 Software for deep brain stimulation (DBS).
Vercise™ Gevia™ deep brain stimulation (DBS) system is a directional neurostimulation device developed by Boston Scientific.
Boston Scientific's fourth-generation Vercise Genus deep brain stimulation system has been implanted in its first ever US surgery.
Notepad++ is a free and open-source source code editor. Prior to 8.9.7, the Notepad++ Windows 11 x64 and ARM64 installer passes the attacker-influenced installation directory `$INSTDIR` from PowerEditor/installer/nppSetup.nsi into a PowerShell `-Command` string used by RegisterMSIX to invoke Add-AppxPackage, allowing PowerShell subexpression syntax such as `$()` in the installation path to execute commands in the installer's security context when the context menu component is selected. This issue is fixed in version 8.9.7.
calibre is an e-book manager. Prior to 9.12.0, the calibre Content Server endpoint POST /book-update-annotations/{library_id}/{book_id}/{fmt} in src/calibre/srv/books.py omits needs_db_write=True, causing Router.dispatch() to skip ctx.check_for_write_access() before update_annotations() passes attacker-controlled JSON to db.merge_annotations_for_book(), which allows a readonly user or an anonymous user on an unauthenticated deployment to persist unauthorized book annotation changes. This issue is fixed in version 9.12.0.
calibre is an e-book manager. Prior to 9.12.0, calibre processes attacker-controlled composite_template metadata from a malicious EPUB, OPF, PDF, or similar file through program: and a nested template() call whose formatter does not inherit allow_python_templates=False, allowing a nested python: template to reach compile_python_template and execute arbitrary Python code when the file is opened or imported. This issue is fixed in version 9.12.0.
Kestra is an open-source, event-driven orchestration platform. Prior to 2.0.0, Kestra's core/src/main/java/io/kestra/core/runners/pebble/functions/HttpFunction.java passes the user-controlled http() uri argument to URI.create() and the server-side HTTP client without restricting private, loopback, or link-local destinations, allowing an unauthenticated attacker to import and execute a flow that accesses internal services or cloud metadata.
Kestra is an open-source, event-driven orchestration platform. Prior to 2.0.0-rc6, Kestra's worker/src/main/java/io/kestra/worker/endpoint/WorkerEndpoint.java serves GET /worker without authentication and serializes the complete live Task object, which can expose commands, environment variables, HTTP headers, connection details, plaintext credentials, and execution identifiers while the main API on port 8080 remains protected. This issue is fixed in 2.0.0-rc6.
curl -i -X GET 'https://api.rankiteo.com/underwriter-getcompany-history?
linkedin_id=axa' -H 'apikey: YOUR_API_KEY_HERE'
Every week, Rankiteo analyzes billions of signals to give organizations a sharper, faster view of emerging risks. With deeper, more actionable intelligence at their fingertips, security teams can outpace threat actors, respond instantly to Zero-Day attacks, and dramatically shrink their risk exposure window.
Rankiteo is a unified scoring and risk platform that analyzes billions of signals weekly to help organizations gain faster, more actionable insights into emerging threats. Empowering teams to outpace adversaries and reduce exposure.